<DOC>
	<DOCNO>NCT02712125</DOCNO>
	<brief_summary>Objective : To assess influence maternal isosorbide mononitrate ( IMN ) vaginal supplementation improve liquor volume woman isolate oligohydramnios . Study Design : Prospective randomize interventional study . Materials Methods : 100 woman singleton pregnancy 28-36 week , isolated oligohydramnios [ amniotic fluid index ( AFI ) &lt; 5 ] enrol study . Before propose intervention , antenatal risk factor study . Patients receive 20 mg isosorbide mononitrate ( IMN ) vaginally . Patient follow 24 hour weekly . The treatment continue till liquor improve significantly delivery . Outcome measure ; mean increase liquor , intervention delivery interval , neonatal outcome study .</brief_summary>
	<brief_title>Nitric Oxide Donors Treatment Isolated Oligohydramnios</brief_title>
	<detailed_description>This prospective randomize interventional study do Obstetrics Gynecology Department , Benha University Hospital , Alkalubia , Egypt August 2013 August 2015 . The study protocol approve Local Ethics Committee write informed consent take patient enter study . The study include 100 woman age 18-35 year singleton pregnancy 28-36 week gestation , diagnose isolated oligohydramnios ( AFI le 5 cm ) . Initially , participant subject routine antenatal history take examination routine ultrasound scan use ( Voluson , 730 Pro V , GE Medical System ) , AFI assess . All participant instruct take regularly daily water requirement , especially two day start study throughout study . Participants randomly schedule two equal group computer-generated block control group receive placebo vaginal tablet study group receive 20 mg isosorbide mononitrate ( IMN ) vaginally daily delivery ( Effox , Mina Pharma Co , Egypt ; license Schwartz Pharma , Germany ) . Treatment allocation conceal use sequentially number opaque seal envelope , open sequentially third person ( study nurse ) . Amniotic fluid index rechecked two day follow weekly till delivery one person avoid interobserver variability . Drug treatment continue volume fluid reach normal value delivery . Antenatal vitamin continue . Primary outcome measure change AFI . Secondary outcome measure side effect isosorbide mononitrate , indication mode delivery , neonatal outcomes regard birth weight , still birth neonatal death , Apgar score need neonatal admission .</detailed_description>
	<mesh_term>Oligohydramnios</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Nitric Oxide Donors</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<criteria>Singleton pregnancy 2836 week gestation , Diagnosed isolated oligohydramnios ( AFI le 5 cm ) . Multiple pregnancy ; Fetal chromosomal congenital abnormality ; Signs fetal distress ; Preterm rupture membrane ; Intrauterine infection ; Receiving treatment oligohydramnios ; History maternal heart disease ; Vasodilator use ; sensitivity NO donor ; Preexisting chronic medical problem .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>